Affordable Treatment
- All
- News
- Videos
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
Ayushman Bharat Scheme Delivers Free Treatment In Jharkhand's Palamu
The Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has proved to be life-changing experience for many residents of Jharkhand's Palamu district because of the free and cashless medical treatment as provisioned unde
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
AIIMS Expansion, Lower TB And Maternal Deaths: J.P. Nadda Highlights Major Advances In Public Healthcare
Under Prime Minister Narendra Modi, the government has made sustained efforts to expand healthcare infrastructure, strengthen medical education and improve access to quality healthcare, said Union Minister for Health and Family Welfare J.P. Nadda.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
PM Modi Extends Wishes On Jan Aushadhi Diwas, Lauds Scheme's Role In Expanding Access To Affordable Medicines
On the occasion of Jan Aushadhi Diwas 2026, Prime Minister Narendra Modi on Saturday extended his wishes to all those associated with the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and to the beneficiaries of the scheme.
-
'What An Eye-Opener': US Man Praises Indian Healthcare System, Says It's 'Far Superior' To The West
An American man praised India's healthcare system, Ayurveda benefits, and affordable, fast medical treatment compared to the US.
-
Ozempic Copycats Arrive: From Rs 11,000 To Rs 3,000, How Patent Expiry Is Reshaping Diabetes Treatment
With patent protection ending, Indian companies have moved quickly to introduce lower-cost versions with monthly therapy expected at around Rs 3,000 to Rs 4,000 for initial doses
-
Weight Loss Injection For ₹900? Three Pharma Firms Launch Affordable Semaglutide, Check Prices
Indian pharmaceutical companies have launched affordable versions of semaglutide injections following a patent expiry, significantly lowering costs for diabetes and weight management treatment and improving access for millions of patients.
-
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
Patent expiry does not signal a change in the medicine itself. Rather, it marks the beginning of wider competition, which typically leads to price reductions and improved availability.
-
Semaglutide Is Not A Quick Fix: Bariatric Surgeon Explains The Right Way To Use It
With generics poised to make semaglutide widely accessible in India, this medication has the potential to transform obesity care. But it cannot replace personalised, long-term treatment plans.
-
Ayushman Bharat Scheme Delivers Free Treatment In Jharkhand's Palamu
The Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) has proved to be life-changing experience for many residents of Jharkhand's Palamu district because of the free and cashless medical treatment as provisioned unde
-
What Are Semaglutide Generics? Here's Why They Matter More In India Now
Semaglutide works by imitating the natural hormone glucagon-like peptide-1 (GLP-1), which plays a key role in managing blood sugar.
-
AIIMS Expansion, Lower TB And Maternal Deaths: J.P. Nadda Highlights Major Advances In Public Healthcare
Under Prime Minister Narendra Modi, the government has made sustained efforts to expand healthcare infrastructure, strengthen medical education and improve access to quality healthcare, said Union Minister for Health and Family Welfare J.P. Nadda.
-
Jan Aushadhi Diwas 2026: How India's Generic Drug Drive Is Saving Lives
Observed every year on March 7, Jan Aushadhi Diwas highlights India's push to make quality generic medicines affordable through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana.
-
PM Modi Extends Wishes On Jan Aushadhi Diwas, Lauds Scheme's Role In Expanding Access To Affordable Medicines
On the occasion of Jan Aushadhi Diwas 2026, Prime Minister Narendra Modi on Saturday extended his wishes to all those associated with the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) and to the beneficiaries of the scheme.
-
'What An Eye-Opener': US Man Praises Indian Healthcare System, Says It's 'Far Superior' To The West
An American man praised India's healthcare system, Ayurveda benefits, and affordable, fast medical treatment compared to the US.
